Synergetics announces new bipolar technology patent

Synergetics has announced that it has received an additional patent covering its bipolar technology through the issuance of U.S. patent number 7,041,096.

This patent will provide protection for this proprietary invention through 2023.

This patented technology is currently being used in the Stryker Pain Management unit and the new Malis(R) Advantage(TM). The Company plans to further use this technology in new products currently in development.

"Jerry Malis and our engineers in Philadelphia continue to lead the field in bipolar circuit technology," said Gregg D. Scheller, President and Chief Executive Officer of Synergetics USA, Inc. "This latest patent represents the pinnacle of circuit design for surgical applications of bipolar technology. It is important to Synergetics to remain the technological leader in those fields in which we participate and this patent is important in maintaining that leadership position as we move forward."